Abstract

Dyspnea, usually precipitated or worsened by exertion, is a cardinal symptom of chronic obstructive pulmonary disease (COPD).
1
Current neurophysiological constructs postulate that there are two main mechanisms by which physical activity may amplify the neural drive to the inspiratory muscles, leading to exertional dyspnea: (a) by increasing the ventilatory demands and (b) by increasing the effort to breathe at a given level of ventilation.
1
In simple terms, dyspnea depends on “how much” ventilation is required and “how well” (in mechanical terms) such ventilation is achieved, respectively. On a purely descriptive perspective, (a) can be understood as the quantitative domain of exertional dyspnea, whereas (b) reflects its qualitative properties
There are several factors, however, that may modulate the severity of exertional dyspnea at a given level of resting functional impairment in patients with COPD.
1
Amongst them, obesity assumes prominence due to its high prevalence.
5
Notably, obesity may affect “how much”6,7 and “how well”
8
ventilation is performed on exertion.
9
For instance, moving a large mass against gravity increases the metabolic cost of work
In the current issue of Chronic Respiratory Disease, Zewari and colleagues 17 dealt with another feature of the obesitydyspnea conundrum in COPD: the influence of exercise modality. Despite the lack of direct comparisons between walking versus cycling and the dearth of physiological measurements on exertion, the authors conclude that even mild-moderate obesity may have a detrimental effect on exercise tolerance and dyspnea in these patients. Some caution, however, should be exerted to interpret their findings; for instance, only the 6-min walk work (distance walked x weight) was higher in the obese group since there were no between-group differences in the 6-min walking distance. Although statistically significant, 010 Borg dyspnea scores on exercise cessation were only slightly higher in obese subjects (average 4 compared to 3.2). Interestingly, anthropometric markers of abdominal adiposity in the obese group appeared to significantly worsen dyspnea and exercise tolerance, likely due to its greater mechanical consequences. 15
Why would walking cause greater dyspnea than cycling in the obese patient?
18
Walking is characteristically associated with greater ventilatory requirements compared to cycling due to (a) higher
There remains, therefore, several unanswered questions on this topic. For instance, it is conceivable that the negative consequences of increased ventilatory demands associated with walking are particularly pronounced in patients with higher “wasted” ventilation in the physiological dead space. 2 Is there an equilibrium point where the putative beneficial effects of mild-moderate obesity on lung mechanics compensate for the negative consequences of increased ventilatory demands? If so, this is likely to vary with exercise intensity and whether there are other sources of ventilation stimuli, such as a low PaO2 or early metabolic acidosis, or not. Are the negative effects of android/central obesity on exertional dyspnea greater on walking than cycling? Are they even greater in subjects with small trunks, that is, shorter patients? Importantly, most studies looked at patients with mild-moderate obesity with only a few patients in the morbid obesity range.
To answer these and other questions, 21 future studies should consider not only the severity of obesity as estimated by body mass index (BMI) but, crucially, body fat distribution in a sizable number of men and women showing a large range of resting functional abnormalities. The same subjects should undergo walking and cycling exercise: their sensory and physiological responses (including operating lung volumes) compared at iso-work rate and iso-ventilation. Ideally, measurements should be repeated after weight loss to determine the directional changes on the quantitative and qualitative domains of exertional dyspnea. 22 Advancing the knowledge on the seeds and consequences of activity-related dyspnea in the obese patient with COPD are likely to directly impact the care of this ever-growing patient subpopulation. 5
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
